TN2018000420A1 - Compositions and methods for the treatment or prevention of oxalate-related disorders - Google Patents
Compositions and methods for the treatment or prevention of oxalate-related disordersInfo
- Publication number
- TN2018000420A1 TN2018000420A1 TNP/2018/000420A TN2018000420A TN2018000420A1 TN 2018000420 A1 TN2018000420 A1 TN 2018000420A1 TN 2018000420 A TN2018000420 A TN 2018000420A TN 2018000420 A1 TN2018000420 A1 TN 2018000420A1
- Authority
- TN
- Tunisia
- Prior art keywords
- oxalate
- compositions
- prevention
- treatment
- methods
- Prior art date
Links
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title abstract 2
- 230000002265 prevention Effects 0.000 title abstract 2
- 208000008852 Hyperoxaluria Diseases 0.000 abstract 1
- 241000605936 Oxalobacter formigenes Species 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000003907 kidney function Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000002250 progressing effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4891—Coated capsules; Multilayered drug free capsule shells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE1650828 | 2016-06-13 | ||
| PCT/EP2017/064422 WO2017216165A1 (en) | 2016-06-13 | 2017-06-13 | Compositions and methods for the treatment or prevention of oxalate-related disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TN2018000420A1 true TN2018000420A1 (en) | 2020-06-15 |
Family
ID=59067657
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TNP/2018/000420A TN2018000420A1 (en) | 2016-06-13 | 2017-06-13 | Compositions and methods for the treatment or prevention of oxalate-related disorders |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US10765709B2 (https=) |
| EP (1) | EP3468572B1 (https=) |
| JP (1) | JP7016353B2 (https=) |
| CN (1) | CN109641019A (https=) |
| AU (1) | AU2017286220A1 (https=) |
| CA (1) | CA3023042A1 (https=) |
| ES (1) | ES2913398T3 (https=) |
| IL (1) | IL263477A (https=) |
| JO (1) | JOP20180110A1 (https=) |
| MA (1) | MA45226A (https=) |
| TN (1) | TN2018000420A1 (https=) |
| WO (1) | WO2017216165A1 (https=) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3468572B1 (en) * | 2016-06-13 | 2022-03-02 | OxThera Intellectual Property AB | Compositions and methods for the treatment or prevention of oxalate-related disorders |
| US20210386793A1 (en) * | 2018-10-04 | 2021-12-16 | Oxthera Intellectual Property Ab | New medical use of oxalate-reducing bacteria |
| CN110607262B (zh) * | 2019-09-25 | 2022-03-25 | 君维安(武汉)生命科技有限公司 | 一种干预炎性肠炎的益生菌组合物及其筛选方法和应用 |
| EP3839039A1 (en) * | 2019-12-16 | 2021-06-23 | 4D Pharma Research Limited | Providing bacterial biomass with improved storage stability |
| BR112022013867A2 (pt) * | 2020-01-14 | 2022-09-13 | Synlogic Operating Co Inc | Bactérias manipuladas para tratar distúrbios nos quais o oxalato é prejudicial |
| CA3175041A1 (en) * | 2020-03-10 | 2021-09-16 | Federation Bio Inc. | Microbial consortia for the treatment of disease |
| EP4043018A1 (en) * | 2021-02-10 | 2022-08-17 | Charité - Universitätsmedizin Berlin | Composition and method for reducing oxalate levels in patients receiving maintenance dialysis |
| CA3216136A1 (en) * | 2021-04-30 | 2022-11-03 | Aaron Blake Cowley | Compositions for preserving anaerobic microorganisms and methods of making and using the same |
| WO2023102091A2 (en) * | 2021-12-01 | 2023-06-08 | Federation Bio, Inc. | Microbial consortia |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5286495A (en) * | 1992-05-11 | 1994-02-15 | University Of Florida | Process for microencapsulating cells |
| BG61712B1 (bg) * | 1994-12-29 | 1998-04-30 | "Ел Би Булгарикум" ЕАД | закваски за българско кисело мляко и млечнокисели продукти и методи за получаването им |
| US6355242B1 (en) | 1997-05-23 | 2002-03-12 | Ixion Biotechnology, Inc. | Materials and methods for treating or preventing oxalate-related disease |
| US8486389B2 (en) * | 1997-05-23 | 2013-07-16 | Oxthera, Inc. | Compositions and methods for treating or preventing oxalate-related disease |
| JP4996780B2 (ja) | 1997-05-23 | 2012-08-08 | オクセラ インコーポレイテッド | シュウ酸塩関連疾患を予防するためのシュウ酸塩分解微生物またはシュウ酸塩分解酵素 |
| WO2005097176A2 (en) | 2004-03-26 | 2005-10-20 | University Of Florida Research Foundation, Inc. | Modulating oxalate transport |
| CA2608862C (en) | 2004-06-11 | 2020-05-05 | Trustees Of Tufts College | Silk-based drug delivery system |
| WO2007070052A2 (en) | 2005-12-14 | 2007-06-21 | Oxthera, Inc. | Pharmaceutical compositions and methods for treating or preventing oxalate-related disease |
| JP5558002B2 (ja) | 2005-12-16 | 2014-07-23 | オクセラ インコーポレイテッド | シュウ酸塩低減化のための組成物および方法 |
| JP5193626B2 (ja) | 2008-02-20 | 2013-05-08 | 日本曹達株式会社 | 微生物農薬製剤の保存方法 |
| US9714456B2 (en) | 2013-01-18 | 2017-07-25 | Allena Pharmaceuticals, Inc. | Crystallized oxalate decarboxylase and methods of use |
| EP3468572B1 (en) * | 2016-06-13 | 2022-03-02 | OxThera Intellectual Property AB | Compositions and methods for the treatment or prevention of oxalate-related disorders |
-
2017
- 2017-06-13 EP EP17730457.3A patent/EP3468572B1/en not_active Not-in-force
- 2017-06-13 JP JP2019517169A patent/JP7016353B2/ja not_active Expired - Fee Related
- 2017-06-13 CA CA3023042A patent/CA3023042A1/en not_active Abandoned
- 2017-06-13 CN CN201780036943.1A patent/CN109641019A/zh active Pending
- 2017-06-13 AU AU2017286220A patent/AU2017286220A1/en not_active Abandoned
- 2017-06-13 ES ES17730457T patent/ES2913398T3/es active Active
- 2017-06-13 MA MA045226A patent/MA45226A/fr unknown
- 2017-06-13 TN TNP/2018/000420A patent/TN2018000420A1/en unknown
- 2017-06-13 WO PCT/EP2017/064422 patent/WO2017216165A1/en not_active Ceased
- 2017-06-13 US US16/308,439 patent/US10765709B2/en not_active Expired - Fee Related
-
2018
- 2018-12-04 IL IL263477A patent/IL263477A/en unknown
- 2018-12-05 JO JOP/2018/0110A patent/JOP20180110A1/ar unknown
-
2020
- 2020-09-02 US US17/010,570 patent/US20210052670A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US20190125807A1 (en) | 2019-05-02 |
| AU2017286220A1 (en) | 2018-12-06 |
| EP3468572A1 (en) | 2019-04-17 |
| WO2017216165A1 (en) | 2017-12-21 |
| CN109641019A (zh) | 2019-04-16 |
| JOP20180110A1 (ar) | 2019-01-30 |
| ES2913398T3 (es) | 2022-06-02 |
| CA3023042A1 (en) | 2017-12-21 |
| US10765709B2 (en) | 2020-09-08 |
| US20210052670A1 (en) | 2021-02-25 |
| EP3468572B1 (en) | 2022-03-02 |
| IL263477A (en) | 2019-01-31 |
| JP2019521182A (ja) | 2019-07-25 |
| MA45226A (fr) | 2019-04-17 |
| JP7016353B2 (ja) | 2022-02-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JOP20180110A1 (ar) | تركيبات وطرق لمعالجة أو الوقاية من اضطرابات متعلقة بأوكسالات | |
| PH12019500521A1 (en) | Pyrazolopyridine derivatives as hpk1 modulators and uses thereof for the treatment of cancer | |
| PH12019502132A1 (en) | Combination therapy for the treatment or prevention of tumours | |
| EA201992722A1 (ru) | N2,n4-дифенилпиримидин-2,4-диаминовое производное, способ его получения и фармацевтическая композиция, содержащая его в качестве активного ингредиента, для профилактики и лечения рака | |
| MX387885B (es) | Inhibidores de ezh2 para tratar linfomas. | |
| HK1247922A1 (zh) | 用於治疗癌症的吲哚胺2，3-双加氧酶抑制剂 | |
| MY199705A (en) | Heterocyclic compounds as immunomodulators | |
| PH12018501084A1 (en) | Heterocyclic compounds as immunomodulators | |
| MY192055A (en) | Compounds and compositions for the treatment or prevention of pathological conditions associated with excess fibrin deposition and/or thrombus formation | |
| MX363243B (es) | Composiciones para tratar cáncer y usos de dichas composiciones. | |
| MX2017000307A (es) | Tratamiento de leucemia con inhibidores de histona deacetilasa. | |
| NZ742987A (en) | Methods for treating conditions associated with masp-2 dependent complement activation | |
| JO3591B1 (ar) | مدرات الافراز مشتقة من اوكسالوباكتير فورميجينيس | |
| WO2015095834A3 (en) | Cancer treatments using erk1/2 and bcl-2 family inhibitors | |
| MX389591B (es) | INHIBIDORES DE ACIDO A-AMINO-ß-CARBOXIMUCONICO SEMIALDEHIDO DESCARBOXILASA | |
| MX2017015012A (es) | Formulaciones tópicas y orales que comprenden taurina y magnesio para la prevención y el tratamiento del acné. | |
| WO2016200614A3 (en) | Bacteria engineered to treat diseases associated with hyperammonemia | |
| PH12017500615A1 (en) | Ophthalmic composition comprising cyclosporine and trehalose | |
| MX2021005904A (es) | Inhibidores de la ácido alfa-amino-beta-carboximucónico semialdehído descarboxilasa. | |
| PH12016501371A1 (en) | Pharmaceutical compositions comprising 15-hepe and methods of treating asthma and lung disorders using same | |
| MX2019004321A (es) | Inhibidores de la acido alfa-amino-beta-carboximuconico semialdehido descarboxilasa. | |
| EA201990930A1 (ru) | Способы, композиции и режимы дозирования для лечения или профилактики связанных с интерфероном-гамма заболеваний | |
| MX2018009662A (es) | Metodo y composicion farmaceutica para tratamiento de neurodegeneracion. | |
| WO2014165713A3 (en) | Treatment of inflammatory conditions by modulation of hyaluronan and hyaluronidase activity | |
| PH12018502318A1 (en) | Compositions and methods for treatment of inflammation of infection of the eye |